Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-14

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this methodological study was to investigate the Turkish validity and reliability of the Parkinson's Disease Dyskinesia Scale (PDYS-26).The scale evaluates choreic dyskinesia.Measures the impact of dyskinesia on activities of daily living in patients with Parkinson's disease.

Hypotheses of the Study:

* Parkinson's Disease Dyskinesia Scale (PDYS-26) is reliable in Turkish.
* Parkinson's Disease Dyskinesia Scale (PDYS-26) is valid in Turkish.

To determine the validity of dyskinesia;

* Tampa Kinesiophobia Scale,
* Mini BesTest,
* Activity Specific Balance Safety Scale (ABC) and
* Parkinson's Disease Questionnaire-39 will be evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale

NCT07253376

Cognition Parkinson's Disease Reliability and Validity +2 more

ENROLLING_BY_INVITATION

Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients With Parkinson's Diagnosis Living in Turkey

NCT06630026

Parkinson Disease Falls Scale Reliability Validity

COMPLETED

Postural Sway of Trunk and Upper Extremity Functional Skills in Atient With Parkinson Disease (pwPD)

NCT07182487

PARKINSON DISEASE (Disorder) Postural Instability Trunk Stability Impairment +1 more

COMPLETED

Balance Confidence and Kinesiophobia in Parkinson's Disease

NCT06751797

Parkinson Disease

RECRUITING

Caregiver Burden in Parkinson's Disease

NCT06892717

Parkinson Disease

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Parkinson's disease, a neurodegenerative disorder affecting the peripheral and central nervous system, dyskinesia is a common symptom that occurs as disease processes progress and leads to disability. The term dyskinesia is a general term that covers many movement disorders. In general, it can be defined as mild to severe abnormal and involuntary muscle movements. In individuals with Parkinson's disease, it is a natural consequence of the neurodegenerative process and a motor complication of the gold standard L-dopa. Assessment of dyskinesia in Parkinson's patients is important for the implementation of appropriate medical, surgical and rehabilitation protocols. There are few scales and patient diaries that clinically assess the effect of interventions for dyskinesia. At the same time, there are deficiencies related to the reliability and validity studies of these existing scales in different languages. Therefore, limitations may arise in the assessment of dyskinesia. For this purpose, our study aims to investigate the reliability and validity of the Parkinson's Disease Dyskinesia Scale (PDYS-26) in Turkish in patients diagnosed with 130 idiopathic Parkinson's patients.In the study, the Parkinson's Disease Dyskinesia Scale (PDYS-26) will be translated into Turkish with the "back translation" method and will be finalized after the approval of the commission consisting of relevant health professionals. The final version of the scale will be applied to Parkinson's patients. To determine the validity of dyskinesia; Tampa Kinesiophobia Scale, Mini BesTest Activity Specific Balance Safety Scale (ABC) and Parkinson's Disease Questionnaire-39 will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Parkinson Disease Dyskinesias Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parkinson Patients with Dyskinesia

Parkinson's disease patients with a Unified Parkinson's Disease Rating Scale (UPDRS) dyskinesia score of ≥1. Participants must meet the inclusion criteria and provide informed consent.

Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Intervention Type OTHER

The Turkish adaptation of the Parkinson's Disease Dyskinesia Scale (PDYS-26) is administered to individuals diagnosed with Parkinson's disease who have a dyskinesia score of ≥1 based on the Unified Parkinson's Disease Rating Scale (UPDRS) dyskinesia item. The scale is used to evaluate dyskinesia severity and assess its clinical applicability in Turkish-speaking populations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

The Turkish adaptation of the Parkinson's Disease Dyskinesia Scale (PDYS-26) is administered to individuals diagnosed with Parkinson's disease who have a dyskinesia score of ≥1 based on the Unified Parkinson's Disease Rating Scale (UPDRS) dyskinesia item. The scale is used to evaluate dyskinesia severity and assess its clinical applicability in Turkish-speaking populations.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with idiopathic Parkinson's disease
* H\&Y stage 1-3
* UPDRS dyskinesia item score ≥1
* Accepting to participate in the study

Exclusion Criteria

* Diagnosis of atypical-secondary parkinsonism
* Severe musculoskeletal, neurological and/or cardiopulmonary problems that may affect the results of the assessment
* Mini Mental State Examination score \< 24

Eligible Sex

ALL

Accepts Healthy Volunteers

No